Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRQR | BMY | AMGN | GILD | REGN |
| Company | Proqr Therapeutics | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.0000 | 48.44 | 267.54 | 67.35 | 903.88 |
| High | 2.0400 | 48.55 | 268.77 | 67.55 | 911.64 |
| Low | 1.8600 | 47.70 | 263.39 | 66.89 | 899.90 |
| Last | 1.9000 | 47.84 | 264.07 | 66.93 | 901.19 |
| Change | -0.1000 | -0.42 | -1.57 | -0.38 | +7.05 |
| % Change | -5.00% | -0.87% | -0.59% | -0.56% | +0.79% |
| Volume | 197,800 | 11,763,000 | 2,175,100 | 5,287,700 | 468,600 |
| 20-Day Average Volume | 156,025 | 11,395,495 | 2,225,995 | 6,258,365 | 440,500 |
| Previous Close | 2.0000 | 48.26 | 265.64 | 67.31 | 894.14 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.2370 | 51.17 | 273.48 | 70.61 | 942.39 |
| 20-Day Raw Stochastic | 5.48% | 2.07% | 2.72% | 0.54% | 12.11% |
| 20-Day Relative Strength | 41.01% | 34.65% | 37.63% | 29.70% | 35.14% |
| Weighted Alpha | -12.46 | -31.08 | +4.99 | -24.05 | +13.20 |
| Today's Opinion | 40% Buy | 56% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 48% Buy | 56% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 88% Buy | 24% Sell | 8% Sell | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.93% since 04/10/24 | -4.87% since 04/10/24 | -0.89% since 04/10/24 | -1.75% since 04/10/24 | -3.74% since 04/10/24 |
| Low | 1.8600 on 04/17/24 | 47.70 on 04/17/24 | 263.39 on 04/17/24 | 66.89 on 04/17/24 | 890.43 on 04/16/24 |
| High | 2.3100 on 04/12/24 | 50.58 on 04/11/24 | 273.00 on 04/11/24 | 69.03 on 04/11/24 | 930.64 on 04/11/24 |
| 1-Month | |||||
| %Chg | -25.78% since 03/15/24 | -8.60% since 03/15/24 | -1.79% since 03/15/24 | -9.17% since 03/15/24 | -6.56% since 03/15/24 |
| Low | 1.8600 on 04/17/24 | 47.70 on 04/17/24 | 263.39 on 04/17/24 | 66.89 on 04/17/24 | 890.43 on 04/16/24 |
| High | 2.6400 on 03/19/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | -33.33% since 01/17/24 | -4.28% since 01/17/24 | -13.16% since 01/17/24 | -22.61% since 01/17/24 | -3.01% since 01/17/24 |
| Low | 1.7000 on 01/22/24 | 47.58 on 02/06/24 | 263.39 on 04/17/24 | 66.89 on 04/17/24 | 890.43 on 04/16/24 |
| High | 2.8200 on 01/18/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +46.15% since 10/17/23 | -16.61% since 10/17/23 | -7.15% since 10/17/23 | -16.84% since 10/17/23 | +7.69% since 10/17/23 |
| Low | 1.1100 on 10/27/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 66.89 on 04/17/24 | 769.19 on 10/27/23 |
| High | 3.2900 on 01/17/24 | 57.59 on 10/18/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 154,575 | 96,960,152 | 141,520,144 | 83,333,008 | 98,916,416 |
| Shares Outstanding, K | 81,355 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 7,050,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -30,430,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 3,540,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -5,920,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.21 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 03/13/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/21/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.43 | 14.24 | 10.02 | 23.79 |